|
gptkbp:instanceOf
|
gptkb:drug
triptan
|
|
gptkbp:approvedBy
|
gptkb:United_Kingdom
gptkb:United_States
1997
|
|
gptkbp:ATCCode
|
N02CC03
|
|
gptkbp:bioavailability
|
40% (oral)
|
|
gptkbp:brand
|
Zomig
Zomig Rapimelt
Zomig-ZMT
|
|
gptkbp:CASNumber
|
139264-17-8
|
|
gptkbp:contraindication
|
ischemic heart disease
uncontrolled hypertension
|
|
gptkbp:discoveredBy
|
gptkb:Zeneca
|
|
gptkbp:drugClass
|
antimigraine agent
|
|
gptkbp:eliminationHalfLife
|
3 hours
|
|
gptkbp:excretion
|
urine
feces
|
|
gptkbp:genericName
|
yes
|
|
gptkbp:hasMolecularFormula
|
C16H21N3O2
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
zolmitriptan
|
|
gptkbp:KEGGID
|
D08667
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:mechanismOfAction
|
serotonin receptor agonist
|
|
gptkbp:metabolism
|
liver
N-desmethyl-zolmitriptan
|
|
gptkbp:pregnancyCategory
|
C (US)
B3 (Australia)
|
|
gptkbp:proteinBinding
|
25%
|
|
gptkbp:PubChem_CID
|
5531
5735
CHEMBL1387
DB00933
|
|
gptkbp:routeOfAdministration
|
oral
nasal
|
|
gptkbp:sideEffect
|
nausea
dizziness
drowsiness
dry mouth
|
|
gptkbp:synonym
|
311C90
Zomig
|
|
gptkbp:UNII
|
2C3O6ZFS9D
|
|
gptkbp:usedFor
|
migraine
cluster headache
|
|
gptkbp:bfsParent
|
gptkb:triptans
|
|
gptkbp:bfsLayer
|
7
|